Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
185750.KS Stock Summary
In the News
185750.KS Financial details
Company Rating
Strong Buy
Market Cap
1004.05B
Income
70.69B
Revenue
1453.16B
Book val./share
19493.01
Cash/share
-
Dividend
-
Dividend %
-
Employees
2.34K
Optionable
No
Shortable
Yes
Earnings
08 Feb 2023
P/E
36.63
Forward P/E
-
PEG
-4.99
P/S
1.78
P/B
4.23
P/C
-
P/FCF
-81.33
Quick Ratio
-
Current Ratio
1.94
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
2.25K
EPS next Y
-
EPS next Q
-
EPS this Y
-95.19%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-38.71%
Revenue last 5Y
8.72%
Revenue Q/Q
4.88%
EPS Q/Q
23.28%
-
-
-
-
SMA20
-1.52%
SMA50
-5.99%
SMA100
-2.79%
Inst Own
-
Inst Trans
-
ROA
6%
ROE
12%
ROC
0.13%
Gross Margin
36%
Oper. Margin
7%
Profit Margin
5%
Payout
-
Shs Outstand
12.2M
Shs Float
7.36M
-
-
-
-
Target Price
-
52W Range
69523.81-99047.62
52W High
-16.81%
52W Low
+18.52%
RSI
46.24
Rel Volume
0.82
Avg Volume
16.27K
Volume
13.33K
Perf Week
-0.48%
Perf Month
-6.58%
Perf Quarter
-10.34%
Perf Half Y
-7.1%
-
-
-
-
Beta
1.09707
-
-
Volatility
524.89%, 2750.36%
Prev Close
-0.48%
Price
82400
Change
0.61%
185750.KS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
Metric | History | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 77.37K | 88.24K | 99.72K | 120.46K | 12.81K | |
Net income per share | 4.71K | 3.91K | 4.98K | 8.47K | 407.25 | |
Operating cash flow per share | 7.15K | 3.93K | 7.14K | 9.64K | 123.01 | |
Free cash flow per share | 5.28K | 1.66K | 4.84K | 6.24K | -371.22 | |
Cash per share | 3.98K | 4.24K | 8.53K | 14.96K | 1.79K | |
Book value per share | 35.14K | 39.56K | 43.75K | 50.98K | 5.4K | |
Tangible book value per share | 34.03K | 38.34K | 42.41K | 49.23K | 5.2K | |
Share holders equity per share | 35.14K | 39.56K | 43.75K | 50.98K | 5.4K | |
Interest debt per share | 9.27K | 9.89K | 11.2K | 12.94K | 2.3K | |
Market cap | 1356.82B | 1011.03B | 922.8B | 1890.43B | 9682.18B | |
Enterprise value | 1413.81B | 1069.56B | 963.94B | 1902.91B | 9787.42B | |
P/E ratio | 25.22 | 23.85 | 17.13 | 20.63 | 226.64 | |
Price to sales ratio | 1.53 | 1.06 | 0.85 | 1.45 | 7.21 | |
POCF ratio | 16.61 | 23.72 | 11.94 | 18.12 | 750.33 | |
PFCF ratio | 22.48 | 56.21 | 17.6 | 28 | -248.64 | |
P/B Ratio | 3.38 | 2.36 | 1.95 | 3.43 | 17.11 | |
PTB ratio | 3.38 | 2.36 | 1.95 | 3.43 | 17.11 | |
EV to sales | 1.6 | 1.12 | 0.89 | 1.46 | 7.28 | |
Enterprise value over EBITDA | 14.11 | 11.5 | 9.74 | 12.63 | 87.02 | |
EV to operating cash flow | 17.31 | 25.09 | 12.47 | 18.24 | 758.49 | |
EV to free cash flow | 23.43 | 59.46 | 18.39 | 28.19 | -251.34 | |
Earnings yield | 0.04 | 0.04 | 0.06 | 0.05 | 0 | |
Free cash flow yield | 0.04 | 0.02 | 0.06 | 0.04 | 0 | |
Debt to equity | 0.05 | 0.11 | 0.05 | 0.1 | 0.24 | |
Debt to assets | 0.4 | 0.39 | 0.41 | 0.42 | 0.46 | |
Net debt to EBITDA | 0.57 | 0.63 | 0.42 | 0.08 | 0.94 | |
Current ratio | 1.64 | 1.91 | 1.7 | 1.87 | 2.08 | |
Interest coverage | 22.16 | 27.93 | 23.67 | 32.02 | 23.51 | |
Income quality | 1.52 | 1.01 | 1.43 | 1.14 | 0.3 | |
Dividend Yield | 0.01 | 0.01 | 0.01 | 0 | 0 | |
Payout ratio | 0.16 | 0.2 | 0.16 | 0.1 | 0.25 | |
Sales general and administrative to revenue | 0.03 | 0.03 | 0.02 | 0.01 | 0.02 | |
Research and developement to revenue | 0.07 | 0.08 | 0.09 | 0.11 | 0.12 | |
Intangibles to total assets | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
Capex to operating cash flow | -0.26 | -0.58 | -0.32 | -0.35 | -4.02 | |
Capex to revenue | -0.02 | -0.03 | -0.02 | -0.03 | -0.04 | |
Capex to depreciation | -0.97 | -1.16 | -1.08 | -1.55 | -1.89 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 61.01K | 59.01K | 70K | 98.57K | 7.03K | |
ROIC | 0.17 | 0.15 | 0.14 | 0.2 | 0.13 | |
Return on tangible assets | 0.08 | 0.06 | 0.07 | 0.1 | 0.04 | |
Graham Net | -15.42K | -15.77K | -14.76K | -12.95K | -1.73K | |
Working capital | 142.86B | 185.82B | 194.07B | 279.49B | 346.92B | |
Tangible asset value | 388.96B | 415.52B | 459.04B | 532.56B | 545B | |
Net current asset value | 92.99B | 109.74B | 144.74B | 205.37B | 186.26B | |
Invested capital | 0.26 | 0.24 | 0.25 | 0.25 | 0.42 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 107.65B | 106.36B | 123.04B | 144.12B | 136.72B | |
Average inventory | 144.95B | 156.58B | 167.01B | 185.57B | 205.14B | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 49.52 | 43.48 | 55.13 | 64.63 | 55.68 | |
Days of inventory on hand | 72.58 | 80.88 | 80.27 | 83.22 | 96.76 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 7.37 | 8.39 | 6.62 | 5.65 | 6.55 | |
Inventory turnover | 5.03 | 4.51 | 4.55 | 4.39 | 3.77 | |
ROE | 0.13 | 0.1 | 0.11 | 0.17 | 0.08 | |
Capex per share | -1.87K | -2.27K | -2.3K | -3.4K | -494.23 |
Quarterly Fundamentals Overview
Last date of statement is 2022-09-30 for Q3
Metric | History | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 |
---|---|---|---|---|---|---|
Revenue per share | 30.32K | 11.52K | 10.86K | 11.65K | 12.22K | |
Net income per share | 190 | 49.9 | 554.55 | 736.91 | 908.45 | |
Operating cash flow per share | 921.96 | -816.81 | 204.96 | 888.89 | 108.66 | |
Free cash flow per share | -77.37 | -1.22K | -155.66 | 615.82 | -251.04 | |
Cash per share | 20.47K | 5.96K | 0 | 0 | 0 | |
Book value per share | 50.34K | 18.01K | 18K | 18.59K | 19.49K | |
Tangible book value per share | 48.51K | 17.35K | 18K | 18.57K | 19.46K | |
Share holders equity per share | 50.34K | 18.01K | 18K | 18.59K | 19.49K | |
Interest debt per share | 21.14K | 7.59K | -20.25 | -77.98 | -62.14 | |
Market cap | 1295.53B | 3487.73B | 3091.83B | 2749.34B | 2469.69B | |
Enterprise value | 1309.78B | 3592.97B | 3091.83B | 2749.34B | 2469.69B | |
P/E ratio | 151 | 556.06 | 44.36 | 29.68 | 21.63 | |
Price to sales ratio | 3.79 | 9.64 | 9.06 | 7.51 | 6.43 | |
POCF ratio | 124.48 | -135.89 | 480.09 | 98.44 | 723.35 | |
PFCF ratio | -1.48K | -90.81 | -632.14 | 142.09 | -313.1 | |
P/B Ratio | 2.28 | 6.16 | 5.47 | 4.71 | 4.03 | |
PTB ratio | 2.28 | 6.16 | 5.47 | 4.71 | 4.03 | |
EV to sales | 3.83 | 9.93 | 9.06 | 7.51 | 6.43 | |
Enterprise value over EBITDA | 39.69 | 300.27 | 98.83 | 123.69 | 70.25 | |
EV to operating cash flow | 125.84 | -139.99 | 480.09 | 98.44 | 723.35 | |
EV to free cash flow | -1.5K | -93.55 | -632.14 | 142.09 | -313.1 | |
Earnings yield | 0 | 0 | 0.01 | 0.01 | 0.01 | |
Free cash flow yield | 0 | -0.01 | 0 | 0.01 | 0 | |
Debt to equity | 0.26 | 0.24 | 0 | 0 | 0 | |
Debt to assets | 0.48 | 0.46 | 0.47 | 0.47 | 0.45 | |
Net debt to EBITDA | 0.43 | 8.8 | 0 | 0 | 0 | |
Current ratio | 2.07 | 2.08 | 1.99 | 1.87 | 1.94 | |
Interest coverage | 34.07 | 3.41 | -39.37 | -11 | -20.14 | |
Income quality | 4.85 | -16.37 | 0.37 | 1.21 | 0.12 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.01 | 0.01 | 0.29 | 0.29 | 0.26 | |
Research and developement to revenue | 0.1 | 0.14 | 0 | 0 | 0 | |
Intangibles to total assets | 0.02 | 0.02 | 0 | 0 | 0 | |
Capex to operating cash flow | -1.08 | 0.5 | -1.76 | -0.31 | -3.31 | |
Capex to revenue | -0.03 | -0.04 | -0.03 | -0.02 | -0.03 | |
Capex to depreciation | -1.64 | -1.72 | -1.41 | -1.02 | -1.34 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 14.67K | 4.5K | 14.99K | 17.56K | 19.96K | |
ROIC | 0.05 | 0.01 | 0.03 | 0.04 | 0.05 | |
Return on tangible assets | 0 | 0 | 0.02 | 0.02 | 0.03 | |
Graham Net | -15.08K | -5.77K | -16.01K | -16.35K | -15.88K | |
Working capital | 366.97B | 346.92B | 340.98B | 329.11B | 343.76B | |
Tangible asset value | 547.6B | 545B | 0 | 0 | 0 | |
Net current asset value | 195.28B | 186.26B | 180.95B | 193.15B | 209.59B | |
Invested capital | 0.42 | 0.42 | 0 | 0 | 0 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 57.01 | 49.02 | 0 | 0 | 0 | |
Days of inventory on hand | 94.2 | 85.17 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 1.58 | 1.84 | 0 | 0 | 0 | |
Inventory turnover | 0.96 | 1.06 | 0 | 0 | 0 | |
ROE | 0 | 0 | 0.03 | 0.04 | 0.05 | |
Capex per share | -999.33 | -405.5 | -360.62 | -273.07 | -359.7 |
185750.KS Frequently Asked Questions
What is Chong Kun Dang Pharmaceutical Corp. stock symbol ?
Chong Kun Dang Pharmaceutical Corp. is a KR stock and trading under the symbol 185750.KS
What is Chong Kun Dang Pharmaceutical Corp. stock quote today ?
Chong Kun Dang Pharmaceutical Corp. stock price is $82400 today.
Is Chong Kun Dang Pharmaceutical Corp. stock public?
Yes, Chong Kun Dang Pharmaceutical Corp. is a publicly traded company.